Suchergebnisse - "Hurrish, Katie"

PubPharm (5)

1

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

enthalten in: Cancer research | 2024

von Su, Y. | Carter, J. | Li, X. | +31

2

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

enthalten in: Biochemical pharmacology | 2024

von Hurrish, K. | Su, Y. | Patel, S. | +26

UpdateOf: Res Sq. 2023 Apr 28;:. - PMID 37162954

3

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and purine biosynthesis

enthalten in: ResearchSquare.com | 2023

von Baran, N. | Hurrish, K. | Su, Y. | +24

4

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis

enthalten in: Research square | 2023

von Hurrish, K. | Su, Y. | Patel, S. | +24

UpdateIn: Biochem Pharmacol. 2023 Dec 10;220:115981. - PMID 38081370

5

Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia

enthalten in: Biochemical pharmacology | 2022

von Hege Hurrish, K. | Qiao, X. | Li, X. | +13

1
[1]